Sexual Arousal Disorder Clinical Trial
Official title:
Effect of a Biodanza Program on Desire, Excitation and Sexual Inhibition in Young Adults. A Randomized Pilot Study
NCT number | NCT03720743 |
Other study ID # | amuelle |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 15, 2018 |
Est. completion date | June 1, 2018 |
Verified date | October 2018 |
Source | Universidad de Almeria |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
the objective of this study was to examine the effects of a 10 weeks biodanza program on the
sexual desire and inhibition/arousal of a sample of healthy young adults.
A randomized clinical study was carried out, involving a total of 86 young adults divided
into Intervention Group (BG) and Control Group (CG), carrying out biodanza sessions during 10
weeks. The Sexual Desire Inventory (SDI) and the Sexual Inhibition/Sexual Arousal-Short Form
Scale (SIS/SES-SF) were completed before and after the intervention.
Status | Completed |
Enrollment | 73 |
Est. completion date | June 1, 2018 |
Est. primary completion date | March 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 30 Years |
Eligibility |
Inclusion Criteria: - at least 18 years old - having correctly completed the online questionnaire. - to attend a minimum of eight Biodanza sessions. Exclusion Criteria: - exceed 30 years old. - the presence of some type of physical or mental disability that could prevent their participation in the therapy or the completion of the questionnaires. |
Country | Name | City | State |
---|---|---|---|
Spain | Universidad de Almería | Almería |
Lead Sponsor | Collaborator |
---|---|
Universidad de Almeria |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sexual desire | Sexual Desire Inventory (SDI) formed by 13 items, divided into dyadic sexual desire (Dyadic SD) (items 1-9) and solitary sexual desire (Solitary SD) (items 10-13), and valued by a Likert scale according to frequency (0 = never, and 7 = more than once a day), and intensity (0 = not desire, and 8 = strong desire), in a total range between 0 and 101 points, being higher the desire the greater the response result. | 3 months | |
Primary | Sexual excitement/sexual inhibition | Sexual Inhibition/Sexual Excitement Scales - Short Form consists of 14 items with responses assessed using a Likert scale 1-4 (1 = completely agree; 4 = completely disagree) that measure three sub-scales: Sexual Excitation Scale (SES) (items 1, 3, 8, 10, 11, 14) with a score range between 4 and 16; Sexual Inhibition Scale 1 (SIS1) (items 4, 9, 12, 13) related to distraction/concentration in sexual performance, with a range between 4 and 16, and Sexual Inhibition Scale 2 (SIS2) (items 2, 5, 6, 7) related to the fear to be discovered or to contract some type of sexually transmitted infection (STI), with a range between 4 and 16. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06445855 -
The Effectiveness of Online Interpersonal Relationships-Based Pyschoeducation in Increasing Sexual Interest and Arousal in Women With Sexual Interest and Arousal Disorder
|
N/A | |
Recruiting |
NCT05039775 -
Clitoral Therapy Device in Alleviating Sexual Dysfunction After Genital Mutilation.
|
N/A | |
Completed |
NCT02570282 -
Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder
|
Phase 2 | |
Recruiting |
NCT05765487 -
Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%
|
Phase 1 | |
Not yet recruiting |
NCT02059798 -
Urinary and Sexual Function Before and After Surgical Decompression of Cervical Myelopathy
|
N/A | |
Completed |
NCT04566783 -
Identification of Etiopathological and Clinical Factors in Persistent Genital Arousal Disorder
|
||
Completed |
NCT03592121 -
Study to Investigate the Effect of AB-101 in Breast Cancer Survivors
|
Early Phase 1 | |
Completed |
NCT00746967 -
An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder
|
Phase 2 | |
Completed |
NCT00425256 -
Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)
|
Phase 2 | |
Completed |
NCT04673708 -
H - Test Usage in Identification of Sexual Orientation Among People.
|
N/A |